Abstract:Peptidyl-prolyl isomerases catalyze the conversion between cis and trans isomers of proline. The cyclophilin family of peptidyl-prolyl isomerases is well known for being the target of the immunosuppressive drug cyclosporin, used to combat organ transplant rejection. There is great interest in both the substrate specificity of these enzymes and the design of isoform-selective ligands for them. However, the dearth of available data for individual family members inhibits attempts to design drug specificity; additionally, in order to define physiological functions for the cyclophilins, definitive isoform characterization is required. In the current study, enzymatic activity was assayed for 15 of the 17 human cyclophilin isomerase domains, and binding to the cyclosporin scaffold was tested. In order to rationalize the observed isoform diversity, the high-resolution crystallographic structures of seven cyclophilin domains were determined. These models, combined with seven previously solved cyclophilin isoforms, provide the basis for a family-wide structure:function analysis. Detailed structural analysis of the human cyclophilin isomerase explains why cyclophilin activity against short peptides is correlated with an ability to ligate cyclosporin and why certain isoforms are not competent for either activity. In addition, we find that regions of the isomerase domain outside the proline-binding surface impart isoform specificity for both in vivo substrates and drug design. We hypothesize that there is a well-defined molecular surface corresponding to the substrate-binding S2 position that is a site of diversity in the cyclophilin family. Computational simulations of substrate binding in this region support our observations. Our data indicate that unique isoform determinants exist that may be exploited for development of selective ligands and suggest that the currently available small-molecule and peptide-based ligands for this class of enzyme are insufficient for isoform specificity.

Depletion of cyclophilins B and C leads to dysregulation of endoplasmic reticulum redox homeostasis

Secretory Kinase Fam20C Tunes Endoplasmic Reticulum Redox State Via Phosphorylation of Ero1α

Redox signaling via the molecular chaperone BiP protects cells against endoplasmic reticulum-derived oxidative stress

Vitamin K epoxide reductase contributes to protein disulfide formation and redox homeostasis within the endoplasmic reticulum

DNAJB12 and DNJB14 are non-redundant Hsp40 redox chaperones involved in endoplasmic reticulum protein reflux

Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin

The unfolded protein response: controlling cell fate decisions under ER stress and beyond

Protein synthesis inhibitors and the chemical chaperone TMAO reverse endoplasmic reticulum perturbation induced by overexpression of the iodide transporter pendrin

Rationale : Mice lacking cyclophilin

Recent Progress and Prospects of the Study of Cyclophilins

Redox Signaling and Unfolded Protein Response Coordinate Cell Fate Decisions under ER Stress

Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer

Opposed regulation of endoplasmic reticulum retention under stress by ERp44 and PDIA6

Diseases Originating from Altered Protein Quality Control in the Endoplasmic Reticulum

The Cyclophilin D/Drp1 Axis Regulates Mitochondrial Fission Contributing to Oxidative Stress-Induced Mitochondrial Dysfunctions in Sh-Sy5y Cells

Perk Is Essential for Translational Regulation and Cell Survival during the Unfolded Protein Response

Pre-emptive Quality Control Protects the ER from Protein Overload via the Proximity of ERAD Components and SRP

Structural and Biochemical Characterization of the Human Cyclophilin Family of Peptidyl-Prolyl Isomerases

Reshaping endoplasmic reticulum quality control through the unfolded protein response

Endoplasmic reticulum: Reduced and oxidized glutathione revisited

Oxidized Low-Density Lipoprotein Inhibits the Degradation of Cyclophilin A Via the Lysosome in Vascular Smooth Muscle Cells.